ARTICLE | Clinical News
PB127: Phase II
November 19, 2001 8:00 AM UTC
Point Biomedical said that in a Phase II trial in the U.S. and U.K. in 54 patients expected to have coronary artery disease, Myocardial Contrast Echocardiography (MCE) using PB127 had good concordance...